Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Cellares in High Demand
Date 02 March 2026

Cellares in High Demand

Introduction Cellares is a leading Integrated Development and Manufacturing Organisation (IDMO) that provides full-fledged manufacturing services to boost scalability and reduce costs. The company be...

Opus's New Gene Therapy Clinical Trial Knocks on the Healthcare Door
Date 30 January 2026

Opus's New Gene Therapy Clinical Trial Knocks on the Healthcare Door

Introduction Opus Genetics, a clinical-inspired biopharmaceutical company known for its one-time adeno-associated virus (AAV)-related gene therapies, sincerely developed them for inherited retinal di...

Signios's new program, along with 10x Genomics, eases researchers' operations
Date 30 January 2026

Signios's new program, along with 10x Genomics, eases researchers' operations

Introduction Signios Bio is a part of MedGenome and provides expertise in bioinformatics and multiomics. The company is sincerely focused on leveraging medicine discovery and precision medicine. Sign...

Boehringer's financial support for inflammatory bowel disease
Date 30 January 2026

Boehringer's financial support for inflammatory bowel disease

Introduction Boehringer Ingelheim, a known biopharmaceutical company, aims on animal health, biopharmaceuticals and human pharmaceuticals. The company is devoted to providing therapies in medical sho...

Roche's Phase 2 results made a worthy contribution in CT-388
Date 30 January 2026

Roche's Phase 2 results made a worthy contribution in CT-388

Introduction Roche Company is a diagnostics and pharmaceuticals champion straight from the Swiss land. The company has marked its position in the healthcare sector for its personalised solutions, mai...

Merz's confident submission to EMA
Date 29 January 2026

Merz's confident submission to EMA

Introduction Merz Therapeutics is a family renowned specialty pharmaceutical company smartly developing and introducing effective therapies for movement disorders, liver disease and neurological cond...

L7 Informatics expectations from AI
Date 29 January 2026

L7 Informatics expectations from AI

Introduction L7 Informatics is a multi-tasking, responsible company that serves the L7/ESP® Enterprise Science Platform to discard data pits in the biotech, healthcare and life sciences industry....

Parkinson's Promising Therapies
Date 29 January 2026

Parkinson's Promising Therapies

Introduction Parkinson’s disease (PD), a neurological disorder, takes place due to the brain’s low capacity to generate required dopamine, showing symptoms such as slowness, plus non-moto...

Corcept's Clinical Ecosystem to upgrade with its Ovarian Cancer Drug Efficacy
Date 29 January 2026

Corcept's Clinical Ecosystem to upgrade with its Ovarian Cancer Drug Efficacy

Introduction Corcept Therapeutics, a popular commercial-driven pharmaceutical company known for its main cortisol modulators, heals extreme oncologic, neurological, metabolic, and endocrinologic cond...

Insilico builds a home for AI models
Date 28 January 2026

Insilico builds a home for AI models

Introduction Insilico Medicine, a famous biotechnology company, is known for its excellence in generative AI. Since 2014, the company has boosted the drug discovery and establishment to the core with...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.